That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested in the Psychedelics...

Redefining how the world approaches, prevents, and heals mental health disorders. LIVE QUOTE Initially founded as a holding group that later became involved in operations, Atai...
psychedelic stock review

CBS News: Inside a Psychedelic Ketamine Therapy Sessions (Video).

Therapy Treatment Performed by Ehave's (EHVVF) Chief Medical Office Receive Rave Reviews and Offers Potential to Save Lives, MIAMI BEACH, Fla. (CBS12) — Last month, the...

Why Isn’t Big Pharma Jumping Into Psychedelics (PsyTech).

Originally in PsyTech Jan 28, 2021. By Tessa Eskin Big Pharma is at a crossroads. The industry’s business model relies largely on returning customers for...

Latest article

Who’s the Next Eric Sprott?

To say Eric Sprott has left a legendary mark on the world of mining investment would be an understatement. With a career spanning five...

Perpetua (PPTA) Raises $300 Million.

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...

Brixton Metals (BBBXF) $0.072, Leaps 62%. On No News.

Institutional Gold Analyst It's always fun to decide on a single word, to describe a 62% single day price gain. Should we use "rose, surged,...